Evercore ISI cuts Ultragenyx Pharma PT to $16.00 from $34.00
Evercore ISI Group cut its price target for Ultragenyx Pharma to $16.00 per share from $34.00 and moved the rating to In-Line from Outperform, per Benzinga.
Ratings actions GMT) Ultragenyx Pharma Cut to In-Line From Outperform by Evercore ISI GroupRatings actions